{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:07:58Z","timestamp":1722888478973},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1992,3,1]],"date-time":"1992-03-01T00:00:00Z","timestamp":699408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[1992,3]]},"DOI":"10.1007\/bf01705030","type":"journal-article","created":{"date-parts":[[2005,6,11]],"date-time":"2005-06-11T21:57:42Z","timestamp":1118527062000},"page":"S116-S123","source":"Crossref","is-referenced-by-count":5,"title":["Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF)","Therapie myelodysplastischer Syndrome mit hohem Leuk\u00e4mierisiko mit niedrig dosiertem Cytosin-Arabinosid und Granulozyten-Macrophagen Kolonie-stimulierendem Faktor (rhGM-CSF)"],"prefix":"10.1007","volume":"20","author":[{"name":"the EORTC Leukaemia Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. H.","family":"Gerhartz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Delmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Zwierzina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"de Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Visiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Fiere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sonneveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Labar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"Hoffbrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Fenaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Thyss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Debucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Coiffier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Sizoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Willemze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Suciu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Solbu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Zittoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01705030_CR1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"J. M. Bennet","year":"1982","unstructured":"Bennet, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralinck, H. R., Sultan, C. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol. 51 (1982) 189\u2013199.","journal-title":"Br. J. Haematol."},{"key":"BF01705030_CR2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1182\/blood.V63.2.314.314","volume":"63","author":"D S. Rosenthal","year":"1984","unstructured":"Rosenthal, D S., Moloney, W. C. Refractory dysmyelopoietic anemia and acute leukemia. Blood 63 (1984) 314\u2013318.","journal-title":"Blood"},{"key":"BF01705030_CR3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2141.1985.tb07329.x","volume":"59","author":"G. J. Mufti","year":"1985","unstructured":"Mufti, G. J., Stevens, J. R., Oscier, D. G., Hamblin, T. J., Machin D. Myelodysplastic syndromes: A scoring system with prognostic significance. Br. J. Haematol. 59 (1985) 425\u2013433.","journal-title":"Br. J. Haematol."},{"key":"BF01705030_CR4","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(197808)42:2+<854::AID-CNCR2820420707>3.0.CO;2-W","volume":"42","author":"J. W. Linman","year":"1978","unstructured":"Linman, J. W., Bagby, G. C. jr. The preleukemic syndrome (hemopoietic dysplasia). Cancer 42 (1978) 854\u2013864.","journal-title":"Cancer"},{"key":"BF01705030_CR5","first-page":"77","volume":"63","author":"G. Tricot","year":"1968","unstructured":"Tricot, G., Mecucci, C., van den Berghe, H. Annotation, evolution of the myelodysplastic syndrome. Br. J. Haematol. 63 (1968) 77\u201383.","journal-title":"Br. J. Haematol."},{"key":"BF01705030_CR6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.1987.tb06893.x","volume":"66","author":"R. E. Clark","year":"1987","unstructured":"Clark, R. E., Ismail, S. A. D., Jacobs, A., Payne, H., Smith, S. A. A randomized trial of 13-cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndrome. Br. J. Haematol. 66 (1987) 77\u201383.","journal-title":"Br. J. Haematol."},{"key":"BF01705030_CR7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood.V71.3.703.703","volume":"71","author":"H. P. Koeffler","year":"1988","unstructured":"Koeffler, H. P., Heitjan, D., Mertelsmann, R., Kolitz, J. E., Schulman, P., Itri, L., Gunter, P., Besa, E. Randomized study of 13-cis retinoic acid vs. placebo in the myelodysplastic disorders. Blood 71 (1988) 703\u2013708.","journal-title":"Blood"},{"key":"BF01705030_CR8","first-page":"91","volume":"4","author":"H. Gisslinger","year":"1990","unstructured":"Gisslinger, H., Chott, A., Linkesch, W., Fritz, E., Ludwig, H. Long-term interferon therapy in myelodysplastic syndromes. Leukemia 4 (1990) 91\u201394.","journal-title":"Leukemia"},{"key":"BF01705030_CR9","first-page":"480","volume":"4","author":"A. T. Maiolo","year":"1990","unstructured":"Maiolo, A. T., Cortelezzi, A., Calori, R., Polli, E. Recombinant interferon \u2014 a first line therapy for high risk myelodysplastic syndromes. Leukemia 4 (1990) 480\u2013485.","journal-title":"Leukemia"},{"key":"BF01705030_CR10","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM198312293092602","volume":"309","author":"J. S. Wisch","year":"1983","unstructured":"Wisch, J. S., Griffin, J. D., Kufe, D. W. Response of preleukemic syndromes to continuous infusion of low-dose cytarabine. N. Engl. J. Med. 309 (1983) 1599\u20131602.","journal-title":"N. Engl. J. Med."},{"key":"BF01705030_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2141.1984.tb06081.x","volume":"58","author":"G. Tricot","year":"1984","unstructured":"Tricot, G., DeBock, R., Dekker, A. W., Boogaerts, M. A., Peetermans, M., Punt, K., Verwilghen, R. L. Low dose cytosine arabinoside (AraC) in myelodasplastic syndromes. Br. J. Haematol. 58 (1984) 231\u2013240.","journal-title":"Br. J. Haematol."},{"key":"BF01705030_CR12","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1200\/JCO.1986.4.12.1857","volume":"4","author":"B. D. Cheson","year":"1986","unstructured":"Cheson, B. D., Jasperse, D. M., Simon, R., Friedman, M. A. A. critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes. J. Clin. Onkol. 4 (1986) 1857\u20131864.","journal-title":"J. Clin. Onkol."},{"key":"BF01705030_CR13","first-page":"153","volume":"2","author":"B. L. Powell","year":"1988","unstructured":"Powell, B. L., Capizzi, R. L., Jackson, D. V. Low-dose AraC for patients with myelodysplastic syndromes. Leukemia 2 (1988) 153\u2013156.","journal-title":"Leukemia"},{"key":"BF01705030_CR14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2141.1984.tb06054.x","volume":"58","author":"H. Ishikura","year":"1984","unstructured":"Ishikura, H., Hiroyoshi, S., Okazaki, T., Mochizuki, T., Iszumi, Y., Yamagishi, M., Uchino, H. The effect of low-dose AraC in acute non-lymphoblastic leukaemias and atypical leukaemia. Br. J. Haematol. 58 (1984) 8\u201318.","journal-title":"Br. J. Haematol."},{"key":"BF01705030_CR15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2141.1986.tb04099.x","volume":"62","author":"J. Mitterm\u00fcller","year":"1986","unstructured":"Mitterm\u00fcller, J., Kolb, H. J., Gerhartz, H. H., Wilmanns, W. In vivo differentiation of leukaemic blasts and effect of low dose AraC in a marrow grafted patient with leukaemic relapse. Br. J. Haematol. 62 (1986) 757\u2013762.","journal-title":"Br. J. Haematol."},{"key":"BF01705030_CR16","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM198806023182215","volume":"318","author":"D. M. Layton","year":"1988","unstructured":"Layton, D. M., Mufti, G. J., Lyons, J., Janssen, J. W. G., Bartram, C. R. Loss of ras oncogene mutation in a myelodysplastic syndrome after low-dose cytarabine therapy. N. Engl. J. Med. 318 (1988) 1468.","journal-title":"N. Engl. J. Med."},{"key":"BF01705030_CR17","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1126\/science.3923623","volume":"228","author":"G. G. Wong","year":"1985","unstructured":"Wong, G. G., Witek, J. S., Temple, P. A., Wilkens, K. M., Leary, A. C., Luxemberg, D. P., Jones, S. S., Brown, E. C., Kay, R. M., Orr, E. C., Shoemaker, C., Golde, D. W., Kaufman, R. J., Hendrick, R. M., Wang, E. A., Clark, S. C. Molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 228 (1985) 810\u2013812.","journal-title":"Science"},{"key":"BF01705030_CR18","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJM198712173172501","volume":"317","author":"S. Vadhan-Raj","year":"1987","unstructured":"Vadhan-Raj, S., Keating, M., LeMaistre, A., Hittelmann, W. N., McCredie, K., Trujillo, J. M., Broxmeyer, H. E., Henney, C., Gutterman, J. U. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N. Engl. J. Med. 317 (1987) 1545\u20131552.","journal-title":"N. Engl. J. Med."},{"key":"BF01705030_CR19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1182\/blood.V72.2.705.705","volume":"72","author":"J. H. Antin","year":"1988","unstructured":"Antin, J. H., Smith, B. R., Holmes, W., Rosenthal, D. S. Phase I\/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. Blood 72 (1988) 705\u2013713.","journal-title":"Blood"},{"key":"BF01705030_CR20","doi-asserted-by":"crossref","first-page":"976","DOI":"10.7326\/0003-4819-110-12-976","volume":"110","author":"R. S. Negrin","year":"1989","unstructured":"Negrin, R. S., Haeuber, D. H., Nagler, A., Olds, L. C., Donlon, T., Souza, L. M., Greenberg, P. L. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor, a phase I-II trial. Ann. Int. Med. 110 (1989) 976\u2013984.","journal-title":"Ann. Int. Med."},{"key":"BF01705030_CR21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1200\/JCO.1989.7.5.629","volume":"7","author":"J. A. Thompson","year":"1989","unstructured":"Thompson, J. A., Lee, D. J., Kidd, P., Rubin, E., Kaufmann, J., Bonnem, E. M., Fefer, A. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects. J. Clin. Oncol. 7 (1989) 629\u2013637.","journal-title":"J. Clin. Oncol."},{"key":"BF01705030_CR22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood.V73.1.31.31","volume":"73","author":"A. Ganser","year":"1989","unstructured":"Ganser, A., V\u00f6lkers, B., Greher, J., Ottmann, O. G., Walther, F., Becher, R., Bergmann, L., Schulz, G., Hoelzer, D. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes \u2014 a phase I\/II trial. Blood 73 (1989) 31\u201337.","journal-title":"Blood"},{"key":"BF01705030_CR23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0002-9343(89)90265-9","volume":"86","author":"Y. Kobayashi","year":"1989","unstructured":"Kobayashi, Y., Okabe, T., Ozawa, K., Chiba, S., Hino, M., Miyazono, K., Urabe, A., Takaku, F. Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: A preliminary report. Am. J. Med. 86 (1989) 178\u2013182.","journal-title":"Am. J. Med."},{"key":"BF01705030_CR24","first-page":"204","volume":"9","author":"M. W. Schuster","year":"1990","unstructured":"Schuster, M. W., Thompson, J. A., Larson, R., Allen, S. L., O'Langhlin, R., Israel, R., Feter, A. Randomized trial of subcutaneous granulocyte-macrophage colony-stimulating factor (GM-CSF) versus observation in patients (pts) with myelodysplastic syndrome (MDS) or aplastic anemia (AA). Proc. Am. Soc. Clin. Oncol. 9 (1990) 204 (abstr.).","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"BF01705030_CR25","first-page":"652","volume":"15","author":"E. Vellenga","year":"1987","unstructured":"Vellenga, E., Delwel, H. R., Touw, I. P., L\u00f6wenberg, B. Patterns of acute myeloid leukemia colony growth in response to recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF). Exp. Hematol. 15 (1987) 652\u2013656.","journal-title":"Exp. Hematol."},{"key":"BF01705030_CR26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1182\/blood.V74.2.565.565","volume":"74","author":"L. M. Budel","year":"1989","unstructured":"Budel, L. M., Touw, I. P., Delwel, R., Clark, S. C., L\u00f6wenberg, B. Interleukin-3 and granulocyte-monocyte colony-stimulating factor receptors on human acute myelocytic leukemia cells and relationship to the proliferative response. Blood 74 (1989) 565\u2013571.","journal-title":"Blood"},{"key":"BF01705030_CR27","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1182\/blood.V70.2.404.404","volume":"70","author":"A. Yuo","year":"1987","unstructured":"Yuo, A., Kitagawa, S., Okabe, T., Urabe, A., Komatsu, Y., Itho, S., Tadaku, F. Recombinant human granulocyte colony-stimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia. Blood 70 (1987) 404\u2013411.","journal-title":"Blood"},{"key":"BF01705030_CR28","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1172\/JCI112615","volume":"78","author":"M. A. Armaout","year":"1988","unstructured":"Armaout, M. A., Wang, E. A., Clark, S. C., Sieff, C. A. Human recombinant granulocyte, macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes. J. Clin. Invest. 78 (1988) 597\u2013601.","journal-title":"J. Clin. Invest."},{"key":"BF01705030_CR29","first-page":"33","volume":"13","author":"K. H\u00f6ffken","year":"1990","unstructured":"H\u00f6ffken, K., Overkam, F., Stirbu, J., Grothey, A., Flasshove, M., Hoelzer, D., Ganser, A. Recombinant human granulocyte-macrophage colony-stimulating factor and low-dose cytosine-arabinoside in the treatment of patients with myelodysplastic syndromes. A phase II study. Onkologie 13 (1990) 33\u201337.","journal-title":"Onkologie"},{"key":"BF01705030_CR30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1182\/blood.V76.3.455.455","volume":"76","author":"A. Ganser","year":"1990","unstructured":"Ganser, A., Bartam, C. R., Ottmann, O. G., Seipelt, G., Janssen, J. W. G., Eder, M., Becher, R., Schulz, G., Hoelzer, G. Stimulating of non-clonal hematopoiesis in patients with hematological disorders by recombinant human GM-CSF or interleukin-3. Blood 76 (1990) 114 a (abstr. 568).","journal-title":"Blood"},{"key":"BF01705030_CR31","first-page":"748","volume":"18","author":"M. Brach","year":"1990","unstructured":"Brach, M., Klein, H., Platzer, E., Mertelsmann, R., Herrmann, F. Effect of interleukin-3 on cytosine arabinoside-mediated cytotoxicity of leukemic myeloblasts. Exp. Haematol. 18 (1990) 748\u2013753.","journal-title":"Exp. Haematol."},{"key":"BF01705030_CR32","first-page":"594","volume":"16","author":"H. E. Broxmeyer","year":"1988","unstructured":"Broxmeyer, H. E., Cooper, S., Williams, D. E., Hangoc, G., Gutterman, J. U., Vadhan-Raj, S. Growth characteristics of marrow hematopoietic progenitor\/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor. Exp. Hematol. 16 (1988) 594\u2013602.","journal-title":"Exp. Hematol."},{"key":"BF01705030_CR33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E. L. Kaplan","year":"1958","unstructured":"Kaplan, E. L., Meier, P. Nonparametric estimations from incomplete observations. J. Am. Stat. Ann. 53 (1958) 457\u2013481.","journal-title":"J. Am. Stat. Ann."},{"key":"BF01705030_CR34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJM198809083191001","volume":"319","author":"K. S. Antman","year":"1988","unstructured":"Antman, K. S., Griffin, J. D., Elias, A., Socinski, M. A., Ryan, L., Cannistra, S. A., Oette, D., Whitley, M., Frei, E., Schnipper, L. E. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N. Engl. J. Med. 319 (1988) 593\u2013598.","journal-title":"N. Engl. J. Med."},{"key":"BF01705030_CR35","unstructured":"Gerhartz, H. H., Stern, A. C., Schmetzer, H., Wolf-Hornung, B., Wilmanns, W.: Placebo-controlled double-blind study of granulocyte-macrophage colony-stimulating factor in chemotherapy-induced leukopenia. 10th Congress, European and African Division, International Society of Hematology, Jerusalem, (1989) 6."},{"key":"BF01705030_CR36","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1056\/NEJM199009273231304","volume":"323","author":"R. Ohno","year":"1990","unstructured":"Ohno, R., Tomonaga, M., Kobayashhi, T., Shirakawa, S., Masaoka, T., Omie, M., Oh, H. Nomura, T., Sakai, Y., Hirano, M., Yokomaku, S., Nakayama, S., Yoshida, Y., Miura, A. B., Morishima, Y., Dohy, H., Niho, Y., Hamajima, N., Takaku, F. Effect of granulocyte colony-stimulation factor after intensive induction therapy in relapsed or refractory acute leukemia. N. Engl. J. Med. 323 (1990) 871\u2013877.","journal-title":"N. Engl. J. Med."},{"key":"BF01705030_CR37","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1182\/blood.V75.9.1766.1766","volume":"75","author":"E. H. Estey","year":"1990","unstructured":"Estey, E. H., Dixon, D., Kantarjian, H. M., Keating, M. J., McCredie, C., Bodey, G. P., Kurzrock, R., Talpaz, M., Freireich, E. J., Deisseroth, A. B., Gutterman, J. U. Treatment of poor prognosis, newly diagnosed acute myeloid leukemia with AraC and recombinant human granulocyte-macrophage colony-stimulating factor. Blood 75 (1990) 1766\u20131769.","journal-title":"Blood"},{"key":"BF01705030_CR38","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1200\/JCO.1989.7.9.1268","volume":"7","author":"B. L\u00f6wenberg","year":"1989","unstructured":"L\u00f6wenberg, B., Zittoun, R., Kerkhofs, H., Jehn, U., Abels, J., Debusscher, L., Cauchie, Ch., Peetermans, M., Solbu, G., Suciu, S., Stryckmanns, P. On the value of intensive remission-induction chemotherapy in elderly patients of 65 + years with acute myeloid leukemia. A randomized phase III study of the EORTC leukemia group. J. Clin. Oncol. 7 (1989) 1268\u20131274.","journal-title":"J. Clin. Oncol."},{"key":"BF01705030_CR39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM198607033150103","volume":"315","author":"E. R. Fearon","year":"1986","unstructured":"Fearon, E. R., Burke, P. J., Schiffer, C. A., Zehnbauer, B. A., Vogelstein, B. Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. N. Engl. J. Med. 315 (1986) 15\u201324.","journal-title":"N. Engl. J. Med."},{"key":"BF01705030_CR40","first-page":"313","volume":"10","author":"M. M. Ribeiro","year":"1990","unstructured":"Ribeiro, M. M., Castro, I., Silva, M. J., Gandra, M., Costa, A., Paneira, M. J., Andrade, J., Gomesm, P., Willemze, R., Gerhartz, H. H. Cytogenetic follow up of patients with myelodysplastic syndromes after treatment with low-dose AraC and\/or GM-CSF. Blood 10 (1990) 313 a (abstr. 1242).","journal-title":"Blood"},{"key":"BF01705030_CR41","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood.V75.9.1770.1770","volume":"75","author":"A. Tefferi","year":"1990","unstructured":"Tefferi, A., Thibodeau, S. N., Solberg, L. A. Clonal studies in the myelodysplastic syndrome using x-linked restriction fragment length polymorphismus. Blood 75 (1990) 1770\u20131773.","journal-title":"Blood"},{"key":"BF01705030_CR42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajh.2830340117","volume":"34","author":"A. Delmer","year":"1990","unstructured":"Delmer, A., Karmochkine, M., Cadiou, M., Gerhartz, H., Zittoun, R. Recurrent spleen enlargement during cyclic granulocyte-macrophage colony-stimulating factor therapy for myelodysplastic syndrome. Am. J. Hematol. 34 (1990) 73\u201374.","journal-title":"Am. J. Hematol."},{"key":"BF01705030_CR43","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1182\/blood.V74.5.1758.1758","volume":"74","author":"J. D. Cason","year":"1989","unstructured":"Cason, J. D., Trujillo, J. M., Esteym, Th., Huh, O., Freireich, E. J., Stass, S. A. Peripheral acute leukemia: high peripheral but low-marrow blast count. Blood 74 (1989) 1758\u20131761.","journal-title":"Blood"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01705030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01705030\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01705030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T17:08:57Z","timestamp":1586279337000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01705030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,3]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1992,3]]}},"alternative-id":["BF01705030"],"URL":"https:\/\/doi.org\/10.1007\/bf01705030","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"type":"print","value":"0300-8126"},{"type":"electronic","value":"1439-0973"}],"subject":[],"published":{"date-parts":[[1992,3]]}}}